Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension

R. Adão (Porto, Portugal), P. Mendes-Ferreira (Porto, Portugal), D. Santos-Ribeiro (Porto, Portugal), C. Maia-Rocha (Porto, Portugal), L. Pimentel (Porto, Portugal), C. Pinto (Porto, Portugal), E. Mulvaney (Dublin, Ireland), H. Reid (Dublin, Ireland), B. Kinsella (Dublin, Ireland), F. Potus (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), M. Rademaker (Christchurch, New Zealand), S. Provencher (Quebec, Canada), S. Bonnet (Quebec, Canada), A. Leite-Moreira (Porto, Portugal), C. Brás-Silva (Porto, Portugal)

Source: International Congress 2018 – Pulmonary hypertension: therapy
Session: Pulmonary hypertension: therapy
Session type: Thematic Poster
Number: 3041
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Adão (Porto, Portugal), P. Mendes-Ferreira (Porto, Portugal), D. Santos-Ribeiro (Porto, Portugal), C. Maia-Rocha (Porto, Portugal), L. Pimentel (Porto, Portugal), C. Pinto (Porto, Portugal), E. Mulvaney (Dublin, Ireland), H. Reid (Dublin, Ireland), B. Kinsella (Dublin, Ireland), F. Potus (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), M. Rademaker (Christchurch, New Zealand), S. Provencher (Quebec, Canada), S. Bonnet (Quebec, Canada), A. Leite-Moreira (Porto, Portugal), C. Brás-Silva (Porto, Portugal). Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension. 3041

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: